Immediate-release tablets are tablets designed to disintegrate and release their medication with no special rate-controlling features, such as special coatings and other techniques. This is the most common type of tablet and examples include, chewable, effervescent, sublingual and buccal tablets.
o. Rapid-release Tablets
Rapid-release tablets, also called rapidly dissolving tablets, rapidly disintegrating tablets, orally-dispersible tablets, quick disintegrating tablets, mouth dissolving tablets, fast disintegrating tablets, fast-dissolving tablets, rapid-dissolving tablets, or porous tablets are characterized by disintegrating or dissolving in the mouth within 1 minute, some within 10 seconds, leaving an easy-to-swallow residue.
Tablets of this type are prepared using very water-soluble excipients designed to wick water into the tablet for rapid disintegration or dissolution without chewing.
Rapid-release tablets offer increased convenience and ease of administration with the potential to improve compliance, especially when swallowing conventional solid oral-dosage forms presents difficulties for the patient.
Notwithstanding these advantages, there are a number of disadvantages and difficulties associated with formulating rapid-release tablets, including drug loading, taste masking, friability, manufacturing costs, and stability of the product.
Examples of rapid-release tablets include Clarinex Reditabs [desloratadine], Schering.
p. Extended-Release Tablets
Extended-release tablets sometimes called controlled-release tablets, prolonged-release, delayed release or sustained release tablets are tablets designed to release their medication in a predetermined manner over a prolonged period of time. These tablet types are categorized into
Those that respond to some physiological condition to release the drug, such as enteric coatings;
Those that release the drug in a relatively steady, controlled manner; and
Those that combine combinations of mechanisms to release pulses of drug such as repeat action tablets.
A typical example of this tablet type is Divalproex-Sodium-Extended-Release-Tablets.
q. Vaginal Tablets/ Vaginal Inserts
Vaginal tablets are uncoated, bullet-shaped, or ovoid tablets designed for vaginal administration. They are prepared by compression and are shaped to fit tightly on plastic inserter devices that accompany the product.
Following insertion, retention and slow dissolution of the tablet occur, releasing the medicaments to provide the local pharmacological effect (e.g. for the treatment of bacterial or fungal infection).
Vaginal tablets may also be used to provide systemic absorption of therapeutic agents. Examples include Gyno-Tiocosid (Neimeth), Gynesatum- Clotrimazole vaginal Tablet (Chazmax Pharmaceutical Industries Limited), Nystamark-Nystatin Vaginal Tablet (Mark Pharmaceuticals) etc.
r. Implantation Tablets/ Implants
These are long-acting sterile tablets designed to provide continuous release of drugs, often over a period of months or a year. They are placed subcutaneously for systemic or local delivery.
Implants are mainly used for the administration of hormones such as testosterone steroids for contraception. They usually contain rate-controlling excipients in addition to the active ingredient(s).
Several types of implants are available including pellets, resorbable microparticles, polymer implants, in situ–forming gel/solid implants, metal/plastic implants, and drug-eluting stents.
Examples of implantation tablets include Implanon – etonogestrel (Organon), Disulfiram Tablet for Implantation etc.
Tablet Excipients/ Ingredients
In tablet formulation, many materials are usually combined at various quantities to produce a tablet that is of good standard. These materials serve different and specialized functions in the tablet. The type and quantity of each raw material used is dependent on the intended tablet type and formulation technique. Tablet Excipients include:
Binders /granulating fluid –e.g., include acacia gum, tragacanth, corn starch, methylcellulose, gelatin, panwar gum, ghatti gum, mucilage of isapol husks, carboxymethylcellulose, methylcellulose, polyvinylpyrrolidone and sugars, such as sucrose, glucose, dextrose, molasses, and lactose etc.
Colouring agents/ Colourants – e.g., FD&C Blue No. 1, FD&C Blue No. 2, FD&C Green No. 3, D&C Green No. 5, D&C Red No. 6, D&C Red No. 21. D&C Red No. 22, D&C Red No. 27 etc.
Advantages of Tablets in the Pharmaceutical industry
Tablets are elegant in appearance and convenient to use.
They are superior to other dosage forms with respect to chemical, physical and microbiological stability.
Tablets provide stable and an accurately measured dosage of drug substance to patients.
Tablets can be formulated to protect unstable drug substances or disguise unpalatable excipients.
Tablets are generally inexpensive to manufacture.
It is easier to mask the unpleasant taste of some APIs in tablets thus improving patient acceptability.
Tablets may be formulated to contain two or more drug substances (even if they are physically or chemically incompatible), thus reducing multiple tablet use.
Tablets may be easily manufactured to show product identification using coloured coatings, embossed markings, and printing.
Tablets may be designed to release their active substance at a particular site within the gastrointestinal tract to reduce side effects, promote absorption at that site or provide a local effect (e.g. ulcerative colitis).
With the exception of proteins which are denatured in the gastrointestinal tract, all classes of therapeutic agents may be administered orally in the form of tablets
Disadvantages of Tablets
The manufacture of tablets requires a series of unit operations (weighing, milling, drying, mixing etc.) thus there is an increased level of product loss at each stage in the formulation process.
The absorption of medicament from tablets is dependent on physiological factors, such as gastric resident/emptying time, and thus, vary from one .patient to another.
The compression properties of certain drug substance are poor and may present problems in their subsequent formulation and manufacture as tablets.
Conclusion
Tablets remain popular as a dosage form, due to the various advantages afforded both to the manufacturer and to the patient. Although the basic mechanical approach for most tablet manufacture has remained the same, efforts are continuously made to understand more clearly the physical characteristics of powder compaction and the factors affecting the availability of the drug substance from the dosage form after oral administration.
References
Allen L. V and Ansel H. C. (2014). Ansel’s Pharmaceutical Dosage Forms and Drug Delivery Systems. Philadelphia: Lipincott Williams and Wilkins.
Jariwala, D. M., Patel, H. P., Desai, C. T., Shah., S. A. and Shah, D. R. (2016). A Review on Multiple Compressed Tablets. Journal of Pharmaceutical Science and Bioscientific Research, 6(3): 371-375.
Jones D. (2008). Fasttrack Pharmaceutics – Dosage Form and Design. London: Pharmaceutical Press.
Sakr, A. A and Alanazi, F. K (2012). Oral Solid Dosage Form. In L.A Felton (Eds.), Remington Essentials of Pharmaceutics (pp. 581-610). London: Pharmaceutical Press
Excellent gathering of knowledge.
This a comprehensive article
Thanks for the compliment.
Absolutely comprehensive article! 👍
Please add typical examples off tablets type with brand name and strength also…in this article…
Hello Javed, we will do that in the next update.
It’s very useful to me
I am glad you found it useful.
how can I cited this article in my thesis?
Pharmapproach (n.d.). Solid Dosage Forms: Tablets. Retrieved July 1, 2020, from https://www.pharmapproach.com/solid-dosage-forms-tablets/
Good Topic
Thanks for the compliment.
its very useful
I am happy you found it useful.
Thank you, this is helpful information.
I am happy you found it useful
thank you very much. the article has helped me to solve my industrial pharmacy assignment on dosage forms. kudos.
You’re welcome
I feel as if this article was made with love and careness. Thanks alot 🌹
You are welcome.
It was very helpful..
Thanks. So glad we could be of help.